Exhibit 5.1
| | |
March 24, 2022 Lowe’s Companies, Inc. 1000 Lowe’s Boulevard Mooresville, North Carolina 28117 | | |
Ladies and Gentlemen:
We have acted as counsel in the State of North Carolina to Lowe’s Companies, Inc., a North Carolina corporation (the “Company”), in connection with the Company’s offering of $750,000,000 aggregate principal amount of its 3.350% Notes due 2027 (the “2027 Notes”), $1,500,000,000 aggregate principal amount of its 3.750% Notes due 2032 (the “2032 Notes”), $1,500,000,000 aggregate principal amount of its 4.250% Notes due 2052 (the “2052 Notes”), and $1,250,000,000 aggregate principal amount of its 4.450% Notes due 2062 (the “2062 Notes” and together with the 2027 Notes, the 2032 Notes, and the 2052 Notes, the Securities”) pursuant to the registration statement on Form S-3 (No. 333-258108) (the “Registration Statement”) filed by the Company with the Securities and Exchange Commission (the “SEC”) under the Securities Act of 1933, as amended (the “Securities Act”), insofar as it relates to the Securities and the prospectus dated July 23, 2021 (the “Base Prospectus”), as supplemented by the prospectus supplement dated March 22, 2022 (the “Prospectus Supplement,” and the Base Prospectus as supplemented by the Prospectus Supplement, the “Prospectus”).
The Securities are governed by and were issued pursuant to the terms of an amended and restated indenture, dated December 1, 1995 (the “Base Indenture”), between the Company and U.S. Bank Trust Company, National Association, as successor trustee (the “Trustee”), as supplemented by a twentieth supplemental indenture, dated March 24, 2022 between the Company and the Trustee (the “Supplemental Indenture,” and, together with the Base Indenture, the “Indenture”).
In connection with this opinion, we have (i) investigated such questions of law, (ii) examined originals or certified, conformed or reproduction copies of such agreements, instruments, documents and records of the Company (including, without limitation, the underwriting agreement dated March 22, 2022 between the Company and the several underwriters named in Schedule A thereto, the Indenture, a facsimile copy of the Securities in global form as executed by the Company and authenticated by the Trustee, resolutions of the Board of Directors adopted on November 13, 2020, the action of pricing committee, dated March 22, 2022 and the Company’s Restated Charter and Bylaws, as amended and restated), such certificates of public officials and such other documents and (iii) received such information from officers and representatives of the Company and others, in each case, as we have deemed necessary or appropriate for the purposes of the opinions hereafter expressed. In all such investigations and examinations, we have assumed the legal capacity and competency of all natural persons executing documents and certificates submitted to us, the genuineness of all signatures, the authenticity of original and certified documents submitted to us, the conformity to original or certified documents of all copies submitted to us as conformed or reproduction copies and that any certificate or document upon which we have relied and which was given or dated earlier than the date of this letter continues to remain accurate, insofar as relevant to the opinions contained herein, from such earlier date through and including the date hereof. As to various questions of fact relevant to the opinions expressed